Stock Report

Download full stock data and analysis for free Last Updated: 24-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Omkar Pharmachem Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 532167

₹7.23

up-down-arrow ₹-0.36 (-4.74%)

As on 23-Oct-2026IST

Market cap

info icon

₹7 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

84.8

P/B Ratio

info icon

0.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 -33.33 -22.22 -8.04 3.13
EBIT -152.94 -125.00 -58.15 -28.49 0.91
Net Profit -160.00 -133.33 -51.41 -24.40 -22.57
EPS -159.73 -133.21 -51.37 -24.37 -22.55
Book Value -- -- 2.18 2.17 2.25
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info 53.9243.7826.9052.9851.69
Net Margin info 36.0936.0920.1437.0534.79
Return on equity info 2.142.220.372.152.07
Return on Capital info 3.062.43--3.022.94
Return on Assets info 2.052.090.372.111.98
Debt to Equity (x) info ----0.000.010.03

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
3.02
2.94
3.20
2.76
Peer Median
--
10.67
24.98
20.19
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

0.37

Lower than Peers by 10.00

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
0.37
2.15
2.07
2.21
2.09
Peer Median
10.37
7.59
20.21
19.34
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

0.37

Lower than Peers by 6.05

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
0.37
2.11
1.98
2.06
1.93
Peer Median
6.42
5.44
12.91
11.01
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

26.90

Higher than Peers by 15.70

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
26.90
52.98
51.69
57.09
49.43
Peer Median
11.21
11.66
11.54
15.47
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

20.14

Higher than Peers by 12.25

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
20.14
37.05
34.79
36.43
33.91
Peer Median
7.89
7.57
9.71
10.37
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
0.00
38.15
35.93
37.13
34.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-22.22

Lower than Peers by 28.10

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
-22.22
--
--
--
100.00
Peer Median
5.88
9.11
-10.85
39.46
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-58.15

Lower than Peers by 54.86

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
-58.15
2.51
-9.47
15.51
1,183.17
Peer Median
-3.29
6.88
-32.98
80.25
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-51.41

Lower than Peers by 52.58

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
-51.41
6.24
-4.40
8.03
-17.30
Peer Median
1.16
16.56
-31.20
77.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-51.37

Lower than Peers by 51.60

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
-51.37
6.24
-4.43
8.04
-17.30
Peer Median
0.23
20.92
--
80.00
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
2.18
2.09
2.24
2.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
0.01
0.03
0.07
0.11
Peer Median
0.05
0.07
0.15
0.25
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
0.01
0.03
0.07
0.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

5.90

Higher than Peers by 4.21

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
5.90
1.56
0.51
0.38
0.30
Peer Median
1.69
1.68
1.57
1.55
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

5.90

Higher than Peers by 4.91

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
5.90
1.56
0.51
0.38
0.30
Peer Median
0.99
1.31
1.19
0.97
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

60.00

Higher than Peers by 49.85

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
60.00
15.75
9.48
6.65
4.73
Peer Median
10.15
7.47
19.21
17.50
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

7.62

Lower than Peers by 5.70

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
7.62
18.00
9.00
24.00
15.00
Peer Median
13.32
14.65
12.34
12.61
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.02

Lower than Peers by 0.77

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
0.02
0.06
0.06
0.06
0.06
Peer Median
0.79
0.86
0.92
1.17
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
49.28
60.23
71.18
36.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

84.78

Higher than Peers by 61.23

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
84.78
--
119.87
127.42
112.33
Peer Median
23.55
40.01
28.36
14.07
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.20

Lower than Peers by 1.47

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
0.20
--
2.46
2.79
2.33
Peer Median
1.67
1.93
2.13
2.38
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
--
--
--
--
--
Peer Median
0.48
0.27
0.45
0.44
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

57.51

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
57.51
34.40
79.65
81.84
79.20
Peer Median
--
22.60
12.16
12.87
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

7

Lower than Peers by 1,676

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Omkar Pharmachem
7
--
23
25
21
Peer Median
1,683
1,454
1,457
1,879
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...